LINC00261

ncRNA information

ncRNA name

LINC00261

Specific or universal ncRNAs

Specific ncRNAs

Class

Long noncoding RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

miR-545-3p/MT1M

Cancer information

Cancer name

Esophageal Squamous Cell Carcinoma

Cancer site

qRT-PCR,Western blot,Luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Down

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Down

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

LINC00261 Suppresses Cisplatin Resistance of Esophageal Squamous Cell Carcinoma Through miR-545-3p/MT1M Axis

Tissue resource

paired esophageal squamous cell carcinoma tumor tissues and adjacent non-tumor tissues

esophageal squamous cell carcinoma cell lines TE-1

esophageal squamous cell carcinoma cell lines ECA109

Experiment

None


Institute

Jiangsu Cancer Hospital

the Chinese Academy of Sciences cell bank

Country

China

China

Continent

Asia

Asia